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ABSTRACT
Objective. To determine the profile of 14 polybrominated diphenyl ethers (PBDEs)
and 23 polychlorinated biphenyls (PCBs) in serum of domestic canines and whether
this was predictive of thyroid hormone status.
Samples. Serum samples were collected from 51 client-owned dogs visiting the
University of California Davis William R. Pritchard Veterinary Medical Teaching
Hospital during 2012 to 2016 for routine appointments. Fifteen dogs were diagnosed
with hypothyroxinemia while 36 were euthyroid.
Procedures. Concentrations of PBDEs and PCBs in canine serum samples were mea-
sured by gas chromatography mass spectrometry. Logistic regression analysis was used
to determine the association between the presence/absence of canine hypothyroxinemia
and the serum concentration of individual PBDE or PCB congeners.
Results. The median concentrations of total PBDE and PCB congeners in the
hypothyroxinemic group were 660 and 1,371 ng/g lipid, respectively, which were
higher than concentrations detected in the control group. However, logistic regression
analysis determined that current concentrations of PBDEs and PCBs in canines were
not significantly associated with hypothyroxinemia. BDE 183 was the only congener
showing near significance (p= 0.068).
Conclusions. PBDE and PCB congeners were detected in all canine samples confirming
ongoing exposure to these pollutants. Because household dogs share the human
environment, they may serve as biosentinels of human exposure to these contaminants.
Subjects Environmental Sciences, Toxicology, Veterinary Medicine, Ecotoxicology
Keywords PBDEs, PCBs, Thyroid hormones, Canine, Hypothyroidism, Hypothyroxinemia
INTRODUCTION
The World Health Organization has reported that thyroid disorders are amongst the
most prevalent of medical conditions (WHO/UNEP, 2013), with primary hypothyroidism
being the most common endocrinopathy in humans and dogs (Milne & Hayes, 1981; Scott-
Moncrieff, 2015). There is an increasing concern that environmental chemicals contribute
to the prevalence of thyroid hormone disorders (Boas, Feldt-Rasmussen & Main, 2012).
This is driven largely by epidemiological and experimental evidence demonstrating that
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environmental chemicals may influence thyroid homeostasis by interfering with thyroid
hormone signaling and regulation (Boas, Feldt-Rasmussen & Main, 2012; Carpenter,
2006; Kim et al., 2014; WHO/UNEP, 2013). Polybrominated diphenyl ethers (PBDEs)
and polychlorinated biphenyls (PCBs) are two structural classes of persistent organic
pollutants for which there is strong evidence of their potential to disrupt thyroid hormone
function (Boas, Feldt-Rasmussen & Main, 2012; Pearce & Braverman, 2009; Zoeller, 2005).
The compounds’ potential toxicity is concerning because their chemical stability and
lipophilic nature allows them to persist in the environment and bioaccumulate. Given
the importance of thyroid hormones in animal and human physiology (Scott-Moncrieff,
2015), evaluating the relationship between the body burden of PBDEs and PCBs to
thyroid hormone status is reasonable. Furthermore, several endocrine diseases of humans,
including diabetes mellitus and hypofunction syndromes of the thyroid, occur similarly in
dogs and cats (Rijnberk, Kooistra & Mol, 2003). Studies have also shown histologically that
thyroiditis in beagles resembled Hashimoto’s disease in humans (Beierwaltes & Nishiyama,
1968; Gosselin, Capen & Martin, 1978). Therefore, a canine animal model may prove
helpful for evaluating the role of environmental determinants of thyroid disease.
Human exposure to thyroid hormone disrupting chemicals is of particular concern;
however, biomonitoring studies are difficult. Human studies that involve biological sample
collection require extensive procedures to obtain necessary informed consent, and face
challenges with enrollment of volunteers and subject privacy. Because of factors like chronic
low-dose exposure, multiple exposure routes, long latency periods, and non-specific health
outcomes, conducting the appropriate human assessment to demonstrate causality is
challenging (Backer et al., 2001). A number of studies have used pet dogs as sentinels
for environmental health to associate contaminants with certain disease states such as
household asbestos exposure with mesothelioma, household application of herbicides
2,4-D with malignant lymphoma, and environmental tobacco smoke with lung cancer
(Backer et al., 2001), with only a few publications characterizing PBDE and PCB exposure
assessments of canines (Ali et al., 2013; EWG, 2008; Mizukawa et al., 2016; Ruiz-Suarez et
al., 2015; Storelli et al., 2009; Venier & Hites, 2011).
Domestic pets, such as cats and dogs, share much of their environment with humans,
thus they may serve as biosentinels of potential human health hazards by providing data on
the contaminants within a defined area and serving as a proxy of human exposure to these
environmental contaminants (Venier & Hites, 2011; Walter et al., 2017). Even though pets
and their owners share the same air, water, and housing, pets are usually free of lifestyle
factors that may confound associations with true risk factors in humans, such as tobacco
use, alcohol and caffeine consumption, poor diet, insufficient physical activity, and low
social class (Schmidt, 2009). Studies have reported over 450 diseases in the domestic dog,
with approximately 360 diseases being analogous to human diseases (Shearin & Ostrander,
2010). Further analyses found that the genome sequence in dogs were more homologous
in sequence to humans than mice. Dogs respond to many toxic chemicals similarly
to humans, developing diseases by comparable pathogenic mechanisms with shorter
latency periods. One example is the use of dogs as an animal model for toxicological
studies of lead exposure (Schmidt, 2009). Canine cancers have also been recognized as
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appropriate models for human cancer studies, particularly non-Hodgkin’s lymphoma
(Takashima-Uebelhoer et al., 2012). The cytochrome P450 enzymes are important catalysts
in metabolism of xenobiotics and chemical toxicology. When comparing different species,
including dogs, rabbits, and monkeys, to man as potential animal models, no species was
similar for all P450 enzyme activities (Bogaards et al., 2000). Between each species, only
some enzymes could be considered similar to man. For instance, CYP2D15 in dogs appears
to have enzymatic activity similar to human CYP2D6 and may be useful in studies based
on metabolism mediated by this enzyme (Zuber, Anzenbacherova & Anzenbacher, 2002).
Therefore, knowledge of body burdens of chemicals in domestic canine populations may
be useful for predicting exposures that pose potential risks to humans (Schilling et al., 1988;
Storelli et al., 2009).
The work described in this study tests the hypothesis that serum collected from pet dogs
will have detectable concentrations of PBDE and PCB congeners that are associated with
thyroid dysfunction. Additionally, the aim of this study was to determine the profile of
PBDEs and PCBs in dogs and to evaluate whether this was predictive of hypothyroxinemia.
MATERIALS AND METHODS
Study population
Serum sampleswere obtained fromclient-owned dogs presented to theWilliamR. Pritchard
VeterinaryMedical Teaching Hospital (VMTH), School of VeterinaryMedicine, University
of California Davis (Davis, CA, USA) during 2012 to 2016 for appointments and stored at
−20 ◦C prior to analysis. Various breeds, such as Labradors, Border Collies, and Terriers,
were included in this study. Sex, age, weight, and breed of the dogs are summarized in
Table S1. A diagnosis of hypothyroidism was based on consistent clinical signs observed by
a VMTH clinician and total serum T4 concentrations measured below the reference range
of 1.0–3.2 µg/dl. Additional thyroid diagnostics, including serum TSH, TSH stimulation
tests, thyroid biopsies or radioactive pertechnetate uptake studies were not performed.
Therefore, we referred to the dogs with low serum total T4 levels as hypothyroxinemic.
Both newly diagnosed cases of canine hypothyroxinemia and dogs receiving treatment for
previously diagnosed hypothyroidism were included in the study. Control samples were
collected randomly from dogs determined to be free of canine hypothyroidism based on
the absence of clinical signs of hypothyroidism or any other endocrine disease. In total, 15
hypothyroxinemic dogs and 38 euthyroid control dogs were enrolled in this study. Two
dogs from the control group were excluded from the analysis; one dog was diagnosed with
hyperthyroidism and the age was unknown in the other. VMTH protocols were followed
to obtain written consent from all owners to permit the use of their dogs’ samples in
this study.
Extraction of analytes
Samples were thawed on ice prior to extraction. Details of the extraction of samples
for PBDE and PCB analytes have been described previously (Lin, Pessah & Puschner,
2013). In brief, 0.25 ml aliquots of serum were transferred into Eppendorf tubes for total
lipids analysis. To the remaining serum sample of 0.25 –0.5 ml aliquots, internal standards
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(Cambridge Isotope Laboratories, Inc., Tewksbury, MA, USA) 1ng 13C12 labeled 2,3′,4,4′,5-
penta BDE (13C12− BDE-118) and 1 ng 13C12 labeled 2,2′,3′,4,5-pentachlorobiphenyl
(13C12-PCB-97) were added before mixing with 0.5 ml of pure formic acid (98+%, ACROS
OrganicsTM, Fisher Scientific, Hampton, NH, USA) vortexing for 1 min, and gravimetric
filtration through Solid Phase Extraction columns (Waters Oasis HLB SPE cartridges;
Milford, MA, USA). Columns were previously conditioned with analytical grade methanol
and ultrapure water with 1% formic acid. For further clean-up, silica cartridges (Sep-pak R©
Light Silica cartridges; Waters, Milford, MA, USA) were placed beneath SPE columns and
analytes were eluted with three washes of 3 ml analytical grade dichloromethane under
vacuum. Eluents were collected in disposable glass tubes containing 100 µL of 1 ng/ml
Mirex (PESTANAL R©, analytical standard; Sigma-Aldrich, St. Louis, MO, USA) as an
internal standard to evaluate instrument performance. Samples were dried under a gentle
stream of nitrogen (Organomation Associates, Inc., Berlin, MA, USA) in a water bath (40
◦C), before being reconstituted in 100 µl of pure isooctane (99%, HPLC Grade, Fisher
Chemical; Hampton, NH, USA). The sample was then transferred into an auto-sampler
vial for analysis. Internal standards (Cambridge Isotope Laboratories, Inc., Tewksbury,
MA, USA) 13C12− BDE-118 and 13C12-PCB-97 were used throughout the extraction
and analytical procedures. Six-point calibration curves consisting of PBDE and PCB
concentrations of 0.1, 0.2, 0.8, 2, 4, and 10, ng/ml were prepared by adding PBDE and
PCB analytical standards (Accustandard, Inc., New Haven, CT, USA) to 0.5 ml of control
human serum (DDC Mass Spect Gold
R©
, MSG 3000; Golden West Biologicals Temecula,
CA, USA). Calibration samples were processed following the same extraction method as
samples from enrolled dogs.
Instrument analysis
Samples extracts were analyzed using gas chromatography coupled with triple quadruple
mass spectrometry (GC/MS/MS, Scion TQ triple quadruple mass spectrometer; Bruker,
Fremont, CA, USA) for BDE-17, -28, -47, -49, -52, -66, -85, -95, -99, -100, -136, -153, -154,
and -183, and PCB-11, -28, -52, -66, -77, -84, -91, -95, -101, -118, -131, -132, -135, -136,
-138, -149, -153, -174, -175, -176, -180, -196, and -202 following a previously published
method (Lin, Pessah & Puschner, 2013). All analytes were quantified using the 6-point
calibration curve with standard concentrations ranging from 0.1–10 ng/ml. Calibration
curves were weighted 1/x. Following analysis, concentrations of analytes extracted from
samples less than 0.5 ml of serum were corrected for volume. The lower limit of detection
(LOD) and quantification (LOQ) were estimated based on a signal-to-noise ratio of 3:1
for the LOD and 10:1 for the LOQ. For statistical analysis, a non-detected congener was
assigned a value of the corresponding LOD divided by 12 .
Quality control
The accuracy of the method was assessed using three quality control (QC) samples of
human control serum (DDC Mass Spect Gold
R©
, MSG 3000; Golden West Biologicals
Temecula, CA, USA) fortified with all PBDEs and PCBs at concentrations of 0.1, 0.8 and
4 ng/ml (Table S2). QC samples were prepared following the same extraction method
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as described for the canine samples and analyzed in parallel with each group of canine
samples. For each group of samples processed and analyzed, the determined concentration
of each PBDE and PCB congener in the QC samples, as quantified by the standard curves,
was required to fall within 70 to 120% of the known concentration of the individual
congener for the data to be included in the final analysis (see Table S2). These parameters
were borrowed from a study by Roszko et al. (2012) investigating PBDEs and PCBs in
vegetable oil and established by the European Union for analytical quality control for
pesticide residue analysis in food and feed (European Commission, 2015; Roszko et al.,
2012). In addition, accuracy and precision were assessed using the certified SRM
R©
1958
NIST reference standard (SRM
R©
1958; National Institute of Standards and Technology
reference standard (NIST), Gaithersburg, MD, USA) as previously described (Lin, Pessah
& Puschner, 2013). Laboratory contamination and cross-contamination were checked by
preparing and analyzing the ultra-pure water samples following the exact same procedures
as used for samples from enrolled dogs. A procedural blank consisting of isooctane was
run with every batch of samples. No contamination was detected when analyzing these
samples by GC-MS/MS. The analytical laboratory participates in the Artic Monitoring and
Assessment Program (also known as AMAP Ring Test of Persistent Organic Pollutants
in Human Serum) (CTQ, 2014) for PBDE and PCB analyses and consistently showed
excellent performance for PBDE congener analysis with a −2<Z’-score <2.
Lipid content determination
Total lipid content was calculated after determination of total cholesterol (TC) and
total triglycerides (TG) in each canine sample as quantified by the UC Davis Health
System Department of Pathology and Laboratory Medicine using standard clinical
chemistry enzymatic methods (Allain et al., 1974; Bucolo & David, 1973). The TC and
TG concentrations were used to calculate the total lipids (TL) for each sample using the
following equation by Phillips:
TL= (2.27)∗TC + TG + 62.3 (mg/dl) (Bernert et al. 2007).
Statistical analysis
The median values and the 10th and 90th percentiles of 14 PBDE and 23 PCB congeners
in canine serum samples were determined. Logistic regression was used to analyze the
association between the presence/absence of canine hypothyroxinemia and the serum
concentration of individual PBDE or PCB congeners. Based on an investigation by Milne
& Hayes (1981), results indicated that potential risk factors for hypothyroidism in dogs
include breed, sex, age, and gonadal status (Milne & Hayes, 1981). Thus, the association
of age, sex, weight, and breed on hypothyroxinemia was investigated using exact Mann–
Whitney and exact chi-square tests of homogeneity, respectively, to determine whether
these variables should be controlled for in the logistic regression models (Table S3). To
account for the various breeds, an online source, The Kennel Club (kennelclub.org.uk), was
used to categorize the breeds into small, medium, and large sizes. For statistical purposes,
small and medium sized breeds were later categorized together. Because the majority of
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the study population was already neutered or spayed, gonadal status was not included as
a confounding variable. Lipid concentrations were compared between groups using exact
Mann Whitney test (Table S3). Additionally, least squares linear regression model was
used to evaluate the relationship between total lipids and each PBDE and PCB congener
(Table S4).
A logistic regression model, including congener concentration and age as continuous
(linear) variables, was used to analyze the association of a given congener concentration
with the odds of hypothyroxinemia while controlling for the influence of age. Results
are reported as odds ratios and 95% confidence intervals (CI) (Table S5). The initial
statistical analysis was done using logistic regression in STATA data analysis and statistical
software (Stata IC/13; StataCorp LP, College Station, TX, USA) which uses the standard
maximum likelihood-based estimator. Due to the small sample size, any congeners which
yielded p-values less than 0.15 were subsequently analyzed by exact logistic regression using
LogXact statistical software (Cytel Software Corporation, Cambridge, MA, USA). P-values
< 0.05 were considered statistically significant.
RESULTS
Study population characteristics
A total of 15 hypothyroxinemic and 36 euthyroid control dogs were included in the
study. The exact Mann–Whitney test, exact chi-square test, and logistic regression analysis
indicated that age, sex, weight, and size were not significantly different between the control
and hypothyroxinemic groups (p= 0.093; p= 0.203; p= 0.536; p= 0.757, respectively;
Table S3); thus sex, weight, and size were not included in the logistic regression analyses.
However, studies in Northern Europe, Japan, and USA have found the prevalence of
hypothyroidism to be higher in elderly canines. In addition, PCB and PBDE concentrations
increase with age (Glynn et al., 2003; Sjödin et al., 2008) Therefore, age was controlled
for in logistic regression analyses to assess the influence of PBDE and PCB congener
concentration on the risk of hypothyroxinemia (WHO/UNEP, 2013). The median age of
hypothyroxinemic dogs in the study group was 10 years (5th–95th percentile, 6.4–12),
compared to the median age of eight years (5th–95th percentile, 3.5–13.6) in the control
group (Table S3).
PBDE and PCB concentrations
The serum concentrations of 14 PBDE and 23 PCB congeners were determined and
normalized to the total lipid concentration for each canine sample. The total lipids did
not vary significantly between the hypothyroxinemic and control dog groups (p= 0.767;
Table S3). Statistics also showed no significant correlation between total lipids and PBDE
and PCB congener concentrations (Table S4). Based on previous data showing that lipid
normalization can account for individual differences that occur with feeding schedules
(Phillips et al., 1989) lipid corrected data was used to account for canine variability in
the timing of blood collection and differences that might occur based on energy balance
disruption in a hypothyroid canine. The distribution of 6PBDEs and 6PCBs for the
hypothyroxinemic and control canine samples are shown in Fig. 1. The mean and median
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Figure 1 Box and whiskers diagram of6PBDEs and6PCBs concentrations in canine samples. The
distribution of measured concentrations are presented as ng/g lipid for control, N = 36, (white boxes) and
hypothyroxinemic, N = 15, (gray boxes) canine samples. The upper and lower boundaries of the boxes
represent the 75th and 25th percentiles, and the line within the boxes indicates the median value. The up-
per whiskers show the 90th and the lower whiskers the 10th percentile. Not all PBDEs and PCBs were de-
tected above LOQ in all animals. For statistical purposes, values found below the LOD were assigned a
value of LOD/2.
values of the 6PBDEs were higher in the hypothyroxinemic group of canine samples
compared to the control group. The mean (±SE) and median (10–90 percentiles) values of
6PBDEs were 523.06 ng/g lipid (± 547.88 ng/g lipid) and 222.64 ng/g lipid (75.27–1555.16
ng/g lipid) for the control group compared to 660.16 ng/g lipid (± 457.33 ng/g lipid) and
660.02 ng/g lipid (70.70–1226.30 ng/g lipid) for the hypothyroxinemic group. Similarly,
the mean and median values of the 6PCBs were higher in the hypothyroxinemic group
of canine samples compared to the control group. The mean (±SE) and median (10–90
percentiles) values of 6PCBs were 1215.95 ng/g lipid (± 1238.28 ng/g lipid) and 576.36
ng/g lipid (238.09–3213.98 ng/g lipid) for the control group compared to 1371.23 ng/g
lipid (± 968.73 ng/g lipid) and 1410.87 ng/g lipid (336.56–2550.27 ng/g lipid) for the
hypothyroxinemic group. However, these observations were not statistically supported by
logistic regression analysis (
∑
PBDEs p= 0.559,∑PCBs p= 0.873).
The distribution of individual PBDE and PCB congener concentrations measured (ng/g
lipid) in the hypothyroxinemic and control groups are shown in Figs. 2 and 3. All congeners
showed a large variation in serum concentrations, all of which were right skewed; whiskers
on the box plot represent the 10th and 90th percentiles. Congeners were only included in
the logistic regression analysis if the detection frequency was ≥ 20%; therefore, BDE 17,
BDE 52, PCB 174, PCB 196, and PCB 77 were excluded. For BDE 17, a concentration of
0.54 ng/g lipid was detected in only one dog from the hypothyroxinemic group. For PCB
77, a concentration of 6.25 ng/g lipid was detected in only one dog from the control group.
BDE 95, PCB 131, PCB 136, PCB 175, PCB 176, and PCB 202 were not detected in any
canine sample.
PBDE and PCB congeners included in the logistic regression analysis are listed in
order of decreasing frequency in Table 1. Odds ratios were determined for each PBDE
and PCB congener, describing the relationship between an elevated concentration of the
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Figure 2 Box and whiskers diagram of individual PBDE congener concentrations in canine samples.
The distribution of measured concentrations are presented as ng/g lipid for control, N = 36, (white boxes)
and hypothyroxinemic, N = 15, (gray boxes) canine samples. The upper and lower boundaries of the
boxes represent the 75th and 25th percentiles, and the line within the boxes indicates the median value.
The upper whiskers show the 90th and the lower whiskers the 10th percentile. Not all PBDEs and PCBs
were detected above LOQ in all animals. For statistical purposes, values found below the LOD were as-
signed a value of LOD/2. * p-value close to significance (≤ 0.05) in exact logistic regression controlling for
age of canine study participants.
Figure 3 Box and whiskers diagram of individual PCB congener concentrations in canine samples.
The distribution of measured concentrations are presented as ng/g lipid for control, N = 36, (white boxes)
and hypothyroxinemic, N = 15, (gray boxes) canine samples. The upper and lower boundaries of the
boxes represent the 75th and 25th percentiles, and the line within the boxes indicates the median value.
The upper whiskers show the 90th and the lower whiskers the 10th percentile.
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Table 1 Median concentrations (range: 10th–90th percentiles) of PBDEs and PCBs (ng/g lipid) and de-
tection frequency (%) in serum of domestic canines.
% All dogs (n= 51) Control dogs (n= 36) Hypothyroxinemic
dogs (n= 15)
PBDEs
BDE 47 92 208.81 (28.02–786.37) 135.24 (20.33–996.16) 401.30 (38.22–754.17)
BDE 99 88 100.90 (3.14–284.90) 38.16 (4.40–357.70) 177.54 (2.27–266.62)
BDE 100 87 15.28 (1.99–52.61) 11.04 (1.24–52.64) 23.71 (2.27–52.61)
BDE 66 79 12.40 (4.59–32.60) 10.92 (3.93–37.11) 17.72 (4.60–32.60)
BDE 49 73 3.37 (1.02–11.22) 2.69 (0.58–11.22) 4.90 (2.04–16.54)
BDE 153 69 7.38 (1.30–20.26) 9.40 (1.47–20.89) 6.05 (1.24–18.14)
BDE 28 58 2.56 (0.68–27.34) 1.45 (0.63–26.38) 14.30 (0.80–30.85)
BDE 85 58 5.54 (1.80–15.99) 5.74 (0.75–23.69) 4.30 (2.39–8.98)
BDE 136 46 2.48 (1.38–16.16) 2.27 (1.25–16.16) 6.51 (1.38–28.07)
BDE 154 38 3.11 (1.39–10.32) 3.11 (1.39–11.83) 3.39 (0.81–8.35)
BDE 183 35 1.96 (0.00–24.75) 0.60 (0.00–22.02) 9.68 (0.00–26.38)
PCBs
PCB 101 100 91.38 (30.46–477.21) 77.00 (28.97–481.66) 223.60 (37.50–408.36)
PCB 11 100 42.81 (21.40–92.80) 46.82 (21.00–111.16) 40.40 (22.96–84.22)
PCB 118 100 122.56 (43.69–498.01) 90.83 (37.81–498.01) 224.24 (51.94–504.02)
PCB 132 100 20.37 (8.45–69.10) 17.52 (8.38–81.42) 37.27 (9.10–68.48)
PCB 138 100 37.49 (15.14–166.59) 31.30 (15.02–180.40) 70.29 (18.57–155.34)
PCB 153 100 15.95 (7.05–72.34) 13.71 (6.81–72.34) 33.47 (14.11–72.36)
PCB 52 98 65.11 (25.49–279.60) 57.93 (25.49–347.98) 136.40 (22.08–270.09)
PCB 66 98 217.48 (57.52–1003.35) 184.25 (64.24–1101.74) 507.15 (26.48–883.55)
PCB 84 98 10.90 (1.94–57.28) 8.49 (1.94–62.23) 25.60 (1.27–57.28)
PCB 95 96 10.23 (1.41–72.98) 8.77 (2.62–91.53) 41.04 (1.07–72.98)
PCB 28 90 9.34 (0.65–30.11) 8.92 (1.06–31.74) 12.26 (0.40–25.68)
PCB 149 75 8.19 (1.51–53.17) 5.28 (1.50–53.17) 26.81 (1.69–59.20)
PCB 91 65 2.10 (0.68–24.70) 1.78 (0.68–26.41) 2.60 (0.77–22.64)
PCB 135 65 8.53 (2.87–36.45) 7.80 (2.72–36.45) 10.51 (2.90–43.38)
PCB 180 60 6.92 (1.88–24.39) 6.87 (1.76–25.82) 6.92 (2.47–18.44)
individual congener and the associated change in the odds of a canine patient having
hypothyroxinemia (Table S5). For clarity of data interpretation, the odds ratios for BDE
100, BDE 99, PCB 11, PCB 132, PCB 138, PCB 149, PCB 153, PCB 52, PCB 84, and PCB
95 are presented corresponding to a 10 ng/g lipid increase in serum concentration because
each of these congeners had a median concentration greater than 10 ng/g lipid for the
hypothyroxinemic group. The odds ratios for BDE 47, PCB 101, PCB 118, and PCB 66 are
presented corresponding to a 100 ng/g lipid increase in serum concentration because each
of these congeners had a median greater than 100 ng/g lipid for the hypothyroxinemic
group. The remaining PBDE and PCB congeners all had median values below 10 ng/g lipid
in the hypothyroid group; their odds ratios are given as proportionate change in the odds of
hypothyroxinemia associated with a 1 ng/g lipid increase in serum concentration. BDE 183
was the only congener that had a positive odds ratio close to being significantly different
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from 1.00 (1.05, 95% CI, 1.00–1.10, p= 0.068), indicating that although not significant
this association was still unlikely to arise by chance under the assumptions of absence of
bias and correctness of model specification. This odds ratio indicates that a 1 ng/g lipid
increase in the serum concentration of BDE 183 was associated with a 5.0% increase in the
odds of canine hypothyroxinemia.
DISCUSSION
In this study, serum concentrations of 14 PBDE and 23 PCB congeners were determined
for 15 hypothyroxinemic and 36 control dogs presented to the UC Davis VMTH. PBDEs
and PCBs were detected in all samples, with BDE 47, BDE 99, PCB 118, PCB 52, and PCB
66 having the highest mean and median concentrations of all the analyzed congeners. An
exact logistic regression model was used to determine whether the concentration of suspect
individual (or the sum of) congeners was significantly correlated with the incidence of
canine hypothyroxinemia. This model was chosen for analysis of congener concentrations
for two reasons: (1) exact logistic regression does not assume normality or equal variance
and (2) it prevents small sample-size bias that can occur as a result of maximum likelihood
estimation in a normal logistic regressionmodel. Results from this study’s logistic regression
analysis determined that current concentrations of PBDEs and PCBs in canines were not
significantly associated with hypothyroxinemia. BDE -47, -99, -100, and -153 and PCB
-28, -77, -95, and -101, were the only congeners from this study with reports of decreased
serum T4 concentrations following exposure from other animal models that studied PBDE
and PCB congeners individually (Desaulniers et al., 1997; Fernie et al., 2005; Khan et al.,
2002). Scientific data remain to be inconsistent and inconclusive regarding the influence of
PBDEs and PCBs on thyroid hormones (Zhao et al., 2015). However, most epidemiological
studies in humans have identified associations between PBDE blood levels and thyroid
hormone levels (Allen et al., 2016). Results of epidemiological studies are strengthened by
rodent and mechanistic studies (Hallgren et al., 2001). Both individual and mixtures of
PCBs can influence circulating thyroid hormone levels (Crofton, 2008). However, toxicity
endpoints do not necessarily behave in a manner predicted by T4 levels in PCB treated
animals. Bansal & Zoeller (2008) observed that PCBs decreased circulating T4 levels and
induced neurotoxic effects; however, when the same level of T4 reduction was induced by
propylthiouracil, a chemical that blocks thyroid hormone synthesis, the same downstream
consequences were not observed (Bansal & Zoeller, 2008). This indicates that PCBs may
exert cellular effects not predicted by the changes in circulating T4 (Bansal & Zoeller, 2008;
WHO/UNEP, 2013). Similar results were observed in a study conducted by Yang et al.
(2009), in which the authors did not find an association between abnormalities of dendritic
growth in rats and altered thyroid hormone levels due to PCB exposure (Yang et al., 2009).
This observation is not well understood, which makes interpreting hormone levels after
PCB and PBDE exposure in a clinical, regulatory, or epidemiological setting difficult.
High canine metabolic rate is a potential reason as to why no association was found
between the current PBDE and PCB levels and hypothyroxinemia. Studies have suggested
that cats tend to accumulate persistent pollutants to a higher extent than dogs because dogs
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are metabolically better equipped at degrading these pollutants (Ruiz-Suarez et al., 2015;
Venier & Hites, 2011). A recent study showed that environmental pollutants, like PCBs,
have higher levels in dog food; thus, dogs have higher dietary intake of them. However,
despite this, plasma levels of PCBs were higher in cats relative to dogs, consistent with
dogs having better metabolizing capabilities (Ruiz-Suarez et al., 2015). Although PBDE
exposure and metabolic studies in dogs are limited, the structural similarity between
PCBs and PBDEs suggests high metabolic capacity for the latter as well (Voorspoels et al.,
2006). Therefore, it is reasonable to believe that metabolism contributes a considerable
role in the toxicokinetics and fate of PBDEs and PCBs, especially in species with higher
metabolic capabilities. Mizukawa et al. (2016) detected hydroxylated PCBs (OH-PCBs) in
the blood samples of both dogs and cats but found only a few OH-PCBs at extremely low
levels in pet food products (Mizukawa et al., 2016). This suggested that OH-PCBs were
formed in vivo from parent compounds. However, congener profiles of OH-PCBs differed
between the two species. Tri- to penta-chlorinated OH-PCB congeners in the cat blood
accounted for approximately 90% of the OH-PCBs. In contrast, hexa- to octa-chlorinated
OH-PCBs (4OH-CB 199 and 4OH-CB 202) were greater in dog blood (Mizukawa et al.,
2016). Kunisue & Tanabe (2009) observed similar results—an elevated composition of
octa-chlorinated OH-PCBs in dogs and raccoon dogs—indicating that these metabolites
could be retained in the blood for a long time compared to lower chlorinated OH-PCB
congeners (Kunisue & Tanabe, 2009).
OH-PCBs are biologically active and formed by oxidative metabolism of PCBs by
cytochrome P450 monooxygenases (Boas et al., 2006; Kunisue & Tanabe, 2009). Because of
their structural resemblance to T4, OH-PCBs can disturb thyroid hormone homeostasis
(Kunisue & Tanabe, 2009). Competitive binding assays have shown that OH-PCBs can bind
to human serum transthyretin (TTR), a carrier protein of T4, and displace T4 from the
serum TTR, suggesting that OH-PCB congeners have a stronger binding affinity for TTR
than either T4 or the parent compounds (Boas, Feldt-Rasmussen & Main, 2012; Kunisue &
Tanabe, 2009; Pearce & Braverman, 2009). Likewise, hydroxylated-PBDEs (OH-PBDEs) are
structurally similar to thyroid hormones andmay also disrupt thyroid homeostasis. In an in
vitro competitive binding assay using human TTR and I-T4 as the displaceable radioligand
PBDEs were able to compete with T4-TTR binding only after metabolic conversion,
suggesting the important role for hydroxylation of PBDEs in their effects on thyroid
homeostasis (Meerts et al., 2000). In addition, the degree of bromination of OH-PBDEs
interferes with thyroid function through different activities on thyroid hormone receptors;
lower-brominated OH-PBDEs bound weakly to thyroid hormone receptors and acted
as agonists, whereas high-brominated compounds were more potent binders and acted
as antagonists (Ren et al., 2013). Evidence of decreased thyroid hormones in offspring
perinatally exposed to PCBs and their hydroxylated metabolites has also been reported
in rats, sled dogs, polar bears, seals, and nesting eagles, indicating potential transfer of
these metabolites across the placenta to the fetus with the possible consequence of altered
thyroid hormone status in newborns (Boas, Feldt-Rasmussen & Main, 2012). Therefore,
hydroxylation and halogenation of PBDEs and PCBs are important factors to consider in
terms of thyroid toxicity.
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Although not statistically significant, the data from this study found higher
concentrations of PBDEs and PCBs in the hypothyroxinemic group compared to the
control group, suggesting potential effects frompollutant exposure cannot be ruled out. The
limitations of a small sample sizemay have contributed to the lack of significant associations
observed. BDE 183 was the only congener showing near-significance (p= 0.068). BDE 183
is considered a marker compound for the octa-mix PBDE formulation. Evidence of BDE
183 in canine serum indicates that components of the octa-mix, which was principally
used in molded parts of computers, televisions, car parts, and other products, are still
entering the environment even though the manufacturing of the mix supposedly ceased
in 2004 (EPA, 2014; Law et al., 2014). Debromination of large reservoirs of BDE 209 in
soils and sediments may yield large quantities of lower-brominated congeners, including
BDE 183 (Law et al., 2014). In in vitro root crude enzyme extracts from maize, ryegrass,
and pumpkin, degradation of BDE 209 yielded congeners BDE 206, BDE 207, BDE 208
and BDE 183, as well as other lower brominated congeners down to BDE 7 (Huang et al.,
2013). In juvenile common sole exposed to six BDE congeners including BDE 209, certain
BDE congeners were detected in fish tissues that were not present in the spiked food, such
as BDE 49, BDE 154, BDE 183, and BDE 202 (Munschy et al., 2011). In this case, the sole
were able to metabolize BDE209 to yield lower brominated congeners (Law et al., 2014;
Munschy et al., 2011). Similar results were also observed in studies involving rainbow trout
and juvenile carp (Kierkegaard et al., 1999; Stapleton et al., 2004). Despite the phase-out
of PBDE commercial mixes, breakdown of larger compounds has become an important
consideration when assessing PBDE exposure sources.
Several studies have documented the occurrence of PBDEs and PCBs in pet dogs
(Tables 2 and 3). Results from the present study show higher PBDE and PCB levels
in dogs in California relative to companion dogs in Indiana and Virginia in the USA,
Pakistan, Japan, and Italy (Tables 2 and 3). In contrast, the mean (±SE) and median
values of 6M-PCBs (PCB-28, -52, -101, -138, -153, and -180) observed in dogs in Spain
(67.1 ± 61.6; 50.10 ng/g lipid; (Ruiz-Suarez et al., 2015) were similar to the levels we
observed in dogs in California (72.81 ± 70.66; 50.12 ng/g lipid). It is important to note
that concentrations observed in Japan were measured in whole blood rather than serum;
therefore, concentrations appear much lower. Generally, PBDE and PCB concentrations
appeared much higher in the United States than most other countries. PBDEs have been
used extensively in products in California until their proposed ban in 2003. Following
the ban in 2004, two commercial formulations, penta-BDE and octa-BDE, were phased
out of production in some US states after a voluntary agreement between the US EPA
and the sole manufacturer of these products (Dodson et al., 2012). Despite the phase out
of many PBDEs used in industry, these compounds persist in our environment due to
their resistance to biodegradation (Bradman et al., 2014; Dodson et al., 2012; Whitehead
et al., 2015). Prior to the ban, California mainly used penta-BDE mixtures, comprised
mainly of BDE-47 and -99 (>70%), with smaller contributions from BDE-100, BDE-153,
and BDE-154 (La, Hale & Harvey, 2006; Stapleton et al., 2012). One epidemiological study
assessed sera PBDEs in mothers and their children from the Bay Area of California and
found that BDE-47, -99, -100, -153 made up ∼90% of serum PBDE content (Eskenazi et
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Table 2 A comparison of PBDE concentrations in canine serum samples with concentrations reported
in Indiana, Virginia, Pakistan, and Japan.
Country USA (CA) USA (IN)a USA (VA)b Pakistanc Japande
N = 51 N = 17 N = 20 N = 16 N = 17
BDE 17 0.54f n.a. n.a. n.a. n.a.
BDE 28 9.68 n.a. 0.0459 n.a. n.a.
BDE 47 343.86 0.44 1.01 0.7 <0.0042
BDE 49 5.23 n.a. n.d. n.a. n.a.
BDE 66 14.92 n.a. n.d. n.a. n.a.
BDE 85 7.96 n.a. 0.0306 n.a. n.a.
BDE 99 125.60 0.33 0.674 0.45 <0.0042
BDE 100 22.12 0.23 0.111 n.a. <0.0042
BDE 153 9.71 0.11 2.01 0.35 <0.0042
BDE 154 4.30 0.098 0.0776 n.a. <0.0042
BDE 183 7.65 n.a. 0.127 n.a. <0.0042
Notes.
Concentrations are given as mean values and expressed in ng/g lipid.
aVenier & Hites (2011).
bEWG (2008).
cAli et al. (2013).
dMizukawa et al. (2016).
eConcentrations from canines in Japan are given in ng/g whole blood wet weight.
fCongener was only detected in one canine sample.
n.a., not applicable; n.d., not detected.
al., 2013) consistent with the composition of flame retardants. Our data agrees with these
trends with the Bay Area having the highest concentrations of BDE-47, -99, and -100. Our
results also agree with a recent study investigating PBDE congener profiles in felines from
California (Walter et al., 2017). In contrast, a feline study conducted in Sweden identified
BDE209 and BDE207 as the most prevalent BDE congeners with BDE99 accounting for
only 13% total body burden, compared to 44% in a US population (Kupryianchyk et
al., 2009). Therefore, regional variability in PBDE congener profile will likely influence
the collinearity of congeners in human, feline, or canine samples. This extends to other
biological as well as environmental matrices. A study by Zota et al. (2008) noted that
PBDE concentrations measured in house dust, and serum and breast milk of humans were
much higher in US samples compared to European samples. This study further researched
regional variation within the US and found the highest levels of PBDEs occurring in the
Western region, including California. The observed high levels of PBDEs appear to be
because of the stringent fire safety laws enacted in the state of California that eventually
impacted products throughout the US Reports have shown that about half of the total
PBDEs and 95%of the penta-BDE usedworldwide were consumed inNorth America (Ali et
al., 2013). Our data showed that depending on the congener, PBDE concentrations in dogs
were approximately 5.5 to 10 times higher compared to levels detected in humans. This is
in agreement with studies in cats; young cats had up to 20 times greater PBDE levels than
the median values reported for US adults (Dye et al., 2007a; Dye et al., 2007b). The major
exposure route for PBDEs in pets is thought to be from household dust (Guo et al., 2012)
as pets spend most of their time on the floor or in areas where dust tends to accumulate.
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Table 3 A comparison of PCB concentrations in canine serum samples with concentrations reported
in Japan and Italy.
Country USA (CA) Japanac Italyb
N = 51 N = 17 N = 91
PCB 28 12.82 <0.0074 n.a.
PCB 52 130.75 <0.0074 2.48
PCB 101 187.46 0.00043 2.87
PCB 138 69.68 0.0012 6.37
PCB 153 31.82 0.0027 5.21
PCB 180 10.06 0.0032 16.01
PCB 77 6.25d n.a. 0.52
PCB 118 209.09 0.00073 2.37
PCB 95 30.80 <0.0074 n.a.
PCB 149 23.95 <0.0074 n.a.
Notes.
Concentrations are given as mean values and expressed in ng/g lipid.
aMizukawa et al. (2016).
bStorelli et al. (2009).
cConcentrations from canines in Japan are given in ng/g whole blood wet weight.
dCongener was only detected in one canine sample.
n.a., not applicable.
Because of the pets’ intensive grooming behaviors, dust ingestion may also contribute to
the elevated PBDE congener levels found in dogs and cats compared with those reported
in humans. This also suggests dogs as suitable sentinels for infants, who often come in
contact with environmental contaminants through their frequent hand-to-mouth activity
and exploratory behavior.
PBDE and PCBs levels have reportedly declined in California and a recent study on
Arctic foxes from Norway reported decreased PBDE and PCB concentrations from 1997 to
2013. The observed decline in concentrations of these pollutants observed in humans and
wildlife suggest a positive impact of governmental policies (Andersen et al., 2015; Guo et
al., 2016). Despite the declining levels of persistent organic pollutants in California, levels
of PBDEs and PCBs in human breast milk were still higher in samples from California than
samples reported from China and New Zealand (Guo et al., 2016). In 2012, the European
Food Safety Authority (EFSA) reported that current dietary exposure to BDE 99 raises
potential health concerns (EFSA, 2011). Results from this study showed 88% detection
frequency for BDE99 in dog serum, with the highest concentration similar to reports in
other states and countries (Table 2). Exposure to these pollutants has been linked to cancers,
neurobehavioral and developmental disorders in addition to thyroid disease (Carpenter,
2006; Kim et al., 2014). Given the current levels of PBDEs and PCBs, potential health
concerns other than thyrotoxicity, such as neurotoxicity, estrogenicity, and carcinogenicity
should also be investigated.
In conclusion, detected levels of PBDEs and PCBs in domestic canines from this study
were not significantly associated with thyroid hormone disruption. Future exposure
studies involving canine models should take into account toxicokinetic parameters, such
as absorption, bioaccumulation, metabolism, and excretion, in order to provide a better
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understanding of the relationship between PBDE and PCB exposure and adverse effects
on animals and humans. Should future research find evidence that PBDEs and PCBs act as
endocrine disrupting chemicals by disrupting thyroid function in pets, this would just add
credence to the hypothesis that such an endocrinopathy could occur in humans as well.
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